Literature DB >> 21476365

Driving simulator sickness: an evidence-based review of the literature.

Sherrilene Classen1, Megan Bewernitz, Orit Shechtman.   

Abstract

OBJECTIVE: Guided by the Occupational Therapy Practice Framework: Domain and Process (2nd edition; American Occupational Therapy Association, 2008), we conducted an evidence-based review on simulator sickness (SS).
METHOD: We searched Web of Science, PubMed, SafetyLit, Google Scholar, and recently published literature. We used the American Academy of Neurology's classification criteria to extract data from 10 studies and assign each a level of 1-4, with "1" indicating the highest level of evidence. We grouped studies that addressed SS into client factors, context and environment factors, and activity demands.
RESULTS: Client factors (i.e., older clients [>70 yr; Level B], women [Level B]) and context/environment factors (e.g., refresh rates, scenario design and duration, simulator configuration, and calibration; Level B) probably increase the rates of SS, whereas activity demands (vection, speed of driving, and postural instability; Level C) possibly contribute to SS.
CONCLUSION: We classified factors contributing to SS and identified the need for randomized trials to identify causes of SS.

Entities:  

Mesh:

Year:  2011        PMID: 21476365     DOI: 10.5014/ajot.2011.000802

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  17 in total

1.  A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone.

Authors:  Arthur A Simen; Cynthia Gargano; Jang-Ho Cha; Melissa Drexel; An Bautmans; Ingeborg Heirman; Tine Laethem; Thomas Hochadel; Lien Gheyle; Kim Bleys; Chan Beals; Aubrey Stoch; Gary G Kay; Arie Struyk
Journal:  Ther Adv Drug Saf       Date:  2015-06

2.  Aging: Older Adults' Driving Behavior Using Longitudinal and Lateral Warning Systems.

Authors:  Dustin J Souders; Neil Charness; Nelson A Roque; Hellen Pham
Journal:  Hum Factors       Date:  2019-07-30       Impact factor: 2.888

Review 3.  A roadmap for interpreting the literature on vision and driving.

Authors:  Cynthia Owsley; Joanne M Wood; Gerald McGwin
Journal:  Surv Ophthalmol       Date:  2015-02-07       Impact factor: 6.048

4.  Manipulations to reduce simulator-related transient adverse health effects during simulated driving.

Authors:  M Jäger; N Gruber; R Müri; U P Mosimann; T Nef
Journal:  Med Biol Eng Comput       Date:  2014-06-03       Impact factor: 2.602

5.  A Pilot Study on EEG-Based Evaluation of Visually Induced Motion Sickness.

Authors:  Ran Liu; Miao Xu; Yanzhen Zhang; Eli Peli; Alex D Hwang
Journal:  J Imaging Sci Technol       Date:  2020-01-31       Impact factor: 0.400

6.  Vection and visually induced motion sickness: how are they related?

Authors:  Behrang Keshavarz; Bernhard E Riecke; Lawrence J Hettinger; Jennifer L Campos
Journal:  Front Psychol       Date:  2015-04-20

7.  Driving and dementia: a clinical decision pathway.

Authors:  Kirsty Carter; Sophie Monaghan; John O'Brien; Andrew Teodorczuk; Urs Mosimann; John-Paul Taylor
Journal:  Int J Geriatr Psychiatry       Date:  2014-05-27       Impact factor: 3.485

8.  Prediction of Fitness to Drive in Patients with Alzheimer's Dementia.

Authors:  Dafne Piersma; Anselm B M Fuermaier; Dick de Waard; Ragnhild J Davidse; Jolieke de Groot; Michelle J A Doumen; Ruud A Bredewoud; René Claesen; Afina W Lemstra; Annemiek Vermeeren; Rudolf Ponds; Frans Verhey; Wiebo H Brouwer; Oliver Tucha
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

9.  Effects of visual flow direction on signs and symptoms of cybersickness.

Authors:  Alireza Mazloumi Gavgani; Deborah M Hodgson; Eugene Nalivaiko
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

10.  Can a novel web-based computer test predict poor simulated driving performance? a pilot study with healthy and cognitive-impaired participants.

Authors:  Tobias Nef; René M Müri; Rahel Bieri; Michael Jäger; Nora Bethencourt; Ioannis Tarnanas; Urs P Mosimann
Journal:  J Med Internet Res       Date:  2013-10-21       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.